+

Products under research

Classification:

Products under research (not used)


  • Product Description
  • Progress
  • Serial Number Project Name Estimated total investment scale

    Current input amount

    Accumulated investment amount Progress or phased results Target to be achieved Technical level Specific application prospects
    1

    Freeze-dried human maniacanine disease vaccine (human diploidcells)

    18,600.00

    7,073.85

    18,252.08

    IIIPeriod ProBed test

    Product listing

    domestic leading

    Prevention of rabiesDisease

    2

    tetravalent chicken embryo streamsusceptible viral lysisVaccines

    40,000.00

    2,795.74

    31,992.34

    IIIPeriod ProBed test

    Product listing domestic leading

    Prevention of influenza

    3

    b type of influenzahemobacterium bindingVaccines

    18,800.00

    1,265.61

    9,463.02

    IIIPeriod ProBed test

    Product listing domestic leading

    Preventionbinvasion caused by Haemophilus influenzae typedisease

    4

    four-needle method of rabies vaccine for human use

    7,000.00

    381.55

    3,360.67

    IIIPeriod ProBed test

    Product listing Domestic innovation

    Add new immunization program for human rabies vaccine

    5

    13 valency pneumonia knotcombined vaccine

    34,000.00

    2,336.68

    6,714.41

    Period ProBed test

    Product listing domestic leading

    Prevention of pneumoniaInvasive disease caused by streptococci

    6

    A GroupCgroup brainmembranococcal polysaccharide conjugate vaccine

    22,400.00

    1,716.03

    14,329.39

    Period ProBed test

    Product listing domestic leading

    PreventionAGroupCgroup meningesinflammation

    7

    15-valent HPV vaccine

    100,000.00

    447.33

    9,979.39

    Get clinical trial approval Product listing Global Innovation

    Prevention by human papilloma virus (HPVCervical cancer and cancer causedPrecancerous lesion

    8

    varicella vaccine

    10,500.00

    451.65

    5,775.20

    Get clinical trial approval

    Product listing domestic leading Prevention of chicken poxand complications
    9

    Bmeningocerebral epidemicMiao

    57,500.00

    201.15

    2,924.30

    Pre-clinical studies

    Product listing Domestic innovation

    Prevention B Groupcaused by meningococcalepidemic cerebrospinal meningitis

    10

    20 Price Pneumonia Ballbacterial conjugate vaccine

    32,700.00

    317.30

    3,350.78

    Pre-clinical studies Product listing Domestic innovation

    Prevention of pneumoniaInvasion by Streptococcusdisease

    11

    Recombinant banded blebRash vaccine

    29,360.00

    617.81

    1,345. 14

    Pre-clinical studies Product listing domestic leading

    Prevention of bandedHerpes

    12

    tetravalent virus flowsensitive split vaccine(MDCKCell

    17, 100.00

    479.35

    4,751.50

    Pre-clinical studies Product listing domestic leading

    Prevention of influenzaInfluenza caused by virus strains

    13

    multivalent hand-foot-mouthVaccines

    13,900.00

    891.53

    4, 147.36

    Pre-clinical studies Product listing Domestic innovation

    Prevention of multipleHand, foot and mouth disease caused by virus infection

    14

    Other projects under researchObjective

    /

    1,632.07

    17,703.20

    -

    -

    -

    -

    Total

    /

    401,860.00

    20,607.65

    134,088.78

    /

    /

    /

    /

Previous Page

Next Page

Previous Page

Next Page

Other Products

Inactivated Japanese Encephalitis Vaccine for Human Use (Vero cell) (IJEV)

SPEEDA-Rabies Vaccine for Human Use (Vero cell) (CPRV)

Rabies Vaccine (Human Diploid Cell) for Human Use, Freeze-dried (HDCV)

Influenza Vaccine (Split Virion), Inactivated, Quadrivalent (QIV)

13-valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV 13)

Recombinant Human Papillomavirus 15-valent Vaccine (Escherichia. Coli) (HPV 15)